Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1969 1
1976 1
1991 1
2000 1
2001 1
2004 1
2007 2
2013 3
2014 1
2015 2
2016 4
2017 7
2018 6
2019 2
2020 4
2021 7
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for S. vernetti
Search for S. Vernetto instead (2 results)
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Marso SP, et al. N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605603 Free PMC article. Clinical Trial.
Biofabrication of synthetic human liver tissue with advanced programmable functions.
Florentino RM, Morita K, Haep N, Motomura T, Diaz-Aragon R, Faccioli LAP, Collin de l'Hortet A, Cetin Z, Frau C, Vernetti L, Amler AK, Thomas A, Lam T, Kloke L, Takeishi K, Taylor DL, Fox IJ, Soto-Gutierrez A. Florentino RM, et al. iScience. 2022 Nov 4;25(12):105503. doi: 10.1016/j.isci.2022.105503. eCollection 2022 Dec 22. iScience. 2022. PMID: 36404924 Free PMC article.
Long-Term Outcomes of Hyperadrenergic Orthostatic Hypotension.
Castro RA, Vernetti PM, Biaggioni I, Raj SR, Kaufmann H, Shibao CA. Castro RA, et al. Res Sq [Preprint]. 2023 Sep 11:rs.3.rs-3318273. doi: 10.21203/rs.3.rs-3318273/v1. Res Sq. 2023. PMID: 37790494 Free PMC article. Preprint.
The hyperadrenergic cohort had a greater phenoconversion rate to multiple system atrophy (p = 0.04), whereas the orthostatic hypotension cohort had greater phenoconversion to Parkinson's disease and dementia with Lewy bodies. CONCLUSIONS: Despite having less severe autonom …
The hyperadrenergic cohort had a greater phenoconversion rate to multiple system atrophy (p = 0.04), whereas the orthostatic hypotension coh …
Modeling oxidative injury response in human kidney organoids.
Przepiorski A, Vanichapol T, Espiritu EB, Crunk AE, Parasky E, McDaniels MD, Emlet DR, Salisbury R, Happ CL, Vernetti LA, MacDonald ML, Kellum JA, Kleyman TR, Baty CJ, Davidson AJ, Hukriede NA. Przepiorski A, et al. Stem Cell Res Ther. 2022 Feb 21;13(1):76. doi: 10.1186/s13287-022-02752-z. Stem Cell Res Ther. 2022. PMID: 35189973 Free PMC article.
President's inaugural address.
Vernetti JP. Vernetti JP. J Am Coll Dent. 1976 Jan;43(1):10-4. J Am Coll Dent. 1976. PMID: 1063181 No abstract available.
Design and evaluation of novel glutaminase inhibitors.
McDermott LA, Iyer P, Vernetti L, Rimer S, Sun J, Boby M, Yang T, Fioravanti M, O'Neill J, Wang L, Drakes D, Katt W, Huang Q, Cerione R. McDermott LA, et al. Bioorg Med Chem. 2016 Apr 15;24(8):1819-39. doi: 10.1016/j.bmc.2016.03.009. Epub 2016 Mar 7. Bioorg Med Chem. 2016. PMID: 26988803 Free PMC article.
Limitations of the Unified Multiple System Atrophy Rating Scale as outcome measure for clinical trials and a roadmap for improvement.
Palma JA, Vernetti PM, Perez MA, Krismer F, Seppi K, Fanciulli A, Singer W, Low P, Biaggioni I, Norcliffe-Kaufmann L, Pellecchia MT, Martí MJ, Kim HJ, Merello M, Stankovic I, Poewe W, Betensky R, Wenning G, Kaufmann H. Palma JA, et al. Clin Auton Res. 2021 Apr;31(2):157-164. doi: 10.1007/s10286-021-00782-w. Epub 2021 Feb 7. Clin Auton Res. 2021. PMID: 33554315 Free PMC article. Review.
Diagnostic Value of Combined Acute Levodopa Challenge and Olfactory Testing to Predict Parkinson's Disease.
Terroba Chambi C, Rossi M, Bril A, Vernetti PM, Cerquetti D, Cammarota A, Merello M. Terroba Chambi C, et al. Mov Disord Clin Pract. 2017 Sep 3;4(6):824-828. doi: 10.1002/mdc3.12517. eCollection 2017 Nov-Dec. Mov Disord Clin Pract. 2017. PMID: 30363402 Free PMC article.
BACKGROUND: The diagnosis of Parkinson's disease (PD) can be challenging early in the disease course, when motor features are subtle. ...RESULTS: After 2 years of follow-up, a PD diagnosis was confirmed in 157 patients who fulfilled United Kingdom Parkinson's Diseas …
BACKGROUND: The diagnosis of Parkinson's disease (PD) can be challenging early in the disease course, when motor features are subtle. …
45 results